Study checks how often Lynch syndrome happens in colon cancer
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This registry study looks at how many people with colon cancer also have Lynch syndrome, an inherited condition that can affect cancer risk. If you enroll, your care team collects basic information from your diagnosis to better estimate how common it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a written consent form to join the study
- You are 18 years or older
- You have colon cancer confirmed under the microscope, or you have two cancers happening at the same time (synchronous tumors)
- You are not currently receiving chemotherapy or radiation for colon cancer at the time of screening
- You haven’t had treatment yet for the second tumor (if you have synchronous tumors)
- If you had cancer treatment before, it must be at least 12 months ago (and your team feels you can follow study steps)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks tumor samples from people having surgery for colorectal cancer to look for a genetic condition called Lynch syndrome, which can increase the risk of other cancers. Finding it early can help you and your family take steps to protect your health.
This study collects blood and stool samples to see how well they can detect colorectal cancer or advanced growths in people with Lynch syndrome (an inherited colon cancer risk) or suspected Lynch syndrome. It may help find cancer or precancer earlier, which can improve next-step decisions.
This study follows adults with Lynch syndrome (an inherited gene change) using regular questionnaires and tracking health over time. It may help researchers understand how the condition progresses and improve care for people with these gene mutations.
This study is testing whether a simple blood test can safely replace some of the more invasive procedures used to monitor people with Lynch syndrome, a condition that increases the risk of certain cancers (especially colorectal and uterine). If the blood test works as well, it could mean fewer colonoscopies and other invasive tests for those with Lynch syndrome.
This study looks at whether certain risk scores and universal tumor screening can help identify people with Lynch syndrome, a genetic condition that raises the risk of colorectal and other cancers. By participating, you may learn more about your genetic risk, which can guide future cancer screening and prevention.
This study looks at the genetics and health of people with Lynch syndrome, a condition that raises the risk for certain cancers. Researchers want to learn more about how different genetic changes affect health over time.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.